<?xml version="1.0" encoding="UTF-8"?>
<ref id="ajh25238-bib-0001">
 <label>1</label>
 <mixed-citation publication-type="journal" id="ajh25238-cit-0001">
  <string-name>
   <surname>Daver</surname>
   <given-names>N</given-names>
  </string-name>, 
  <string-name>
   <surname>Kantarjian</surname>
   <given-names>H</given-names>
  </string-name>, 
  <string-name>
   <surname>Ravandi</surname>
   <given-names>F</given-names>
  </string-name>, et al. 
  <article-title>A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high‐risk myelodysplastic syndrome</article-title>. 
  <source xml:lang="en">Leukemia.</source>
  <year>2016</year>;
  <volume>30</volume>:
  <fpage>268</fpage>‐
  <lpage>273</lpage>.
  <pub-id pub-id-type="pmid">26365212</pub-id>
 </mixed-citation>
</ref>
